ST Xiangxue: Transfer 100% equity of Jiujie biotechnology to Xiangxue High-tech for free

On March 30, Sina Finance reported that ST Xiangxue announced that, in order to further optimize the integration of the company's internal resources, enhance the professional management of asset allocation and business, the 100% equity of its wholly-owned subsidiary, Guangdong Jiuji Biological Technology Co., Ltd., was transferred to the company's wholly-owned subsidiary Guangzhou Xiangxue High-tech Investment Co., Ltd. at book value.